Narnatumab

DB14964Investigational

Narnatumab is under investigation in clinical trial NCT01119456 (A Study of IMC-RON8 in Advanced Solid Tumors).

Mechanism: Pharmacologically active on Macrophage-stimulating protein receptor
Curator reviewed
Code names: IMC-RON8

Resolves to

Compound

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Narnatumab, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.